NCT07578714 Core Stability, Postural Balance, and Flexibility in Healthy Women: A Comparative Study Between Pilates Practitioners and Sedentary Individuals
| NCT ID | NCT07578714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istinye University |
| Condition | Core Stability |
| Study Type | OBSERVATIONAL |
| Enrollment | 55 participants |
| Start Date | 2026-05-13 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 55 participants in total. It began in 2026-05-13 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare core muscle stability, postural balance, and flexibility between healthy women who regularly practice Pilates and those with a sedentary lifestyle. The researcher will evaluate if long-term Pilates practice (5 months or more) leads to significant improvements in physical performance compared to a lack of regular exercise. Assessment tools include the Pressure Biofeedback Unit (PBU) for core activation, the McGill battery for endurance, the Y-Balance test for dynamic stability, and the Sit-and-Reach test for flexibility.
Eligibility Criteria
Inclusion Criteria: 1. Healthy female volunteers aged 20-45. 2. For the Pilates group: having practiced mat Pilates, reformer Pilates, or any equipment-based Pilates discipline for at least 6 months; attending regular 60-minute sessions at least twice a week with a certified instructor. 3. For the control group: having a sedentary lifestyle (weekly moderate physical activity time less than 150 minutes). 4. Objectively demonstrating sedentary status using the International Physical Activity Questionnaire (IPAQ); only participants in the "low physical activity" category will be included in the control group. 5. Having full cognitive ability to understand, follow, and execute all physical assessment instructions. 6. Willingness to voluntarily sign the informed consent form prior to the study. Exclusion Criteria: 1. History of any surgery involving the spine, pelvis, or lower extremities within the last 12 months prior to the study. 2. Currently pregnant or less than 6 months postpartum. 3. Diagnosed vestibular disorders or chronic clinical balance disorders. 4. History of neurological disease (MS, Parkinson's, etc.) or systemic metabolic disorder (diabetes, etc.). 5. Having a pain intensity greater than 2/10 on the visual analog scale (VAS) in the lower back or lower extremities. 6. Professional sports history or participation in other exercise programs exceeding 3 hours per week (excluding Pilates for the Pilates group). 7. Acute musculoskeletal injuries or acute illnesses that may affect energy levels on the day of evaluation. 8. Concurrent participation in other intensive core strengthening programs such as "advanced yoga" that may affect results.
Contact & Investigator
NALAN Soydaş, PhD
STUDY DIRECTOR
Istinye University
Frequently Asked Questions
Who can join the NCT07578714 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 45 Years, studying Core Stability. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07578714 currently recruiting?
Yes, NCT07578714 is actively recruiting participants. Contact the research team at 2433095066@stu.istinye.edu.tr for enrollment information.
Where is the NCT07578714 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07578714 clinical trial?
NCT07578714 is sponsored by Istinye University. The principal investigator is NALAN Soydaş, PhD at Istinye University. The trial plans to enroll 55 participants.